Anika Therapeutics Inc. (ANIK)

Last Three Months

21-Jan-24 -- 20-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Reduce

Insider Trading Sentiment: Reduce

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

27

0

4

+1

0

+2

0

+3

Two Year Chart

21-Apr-22 -- 20-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
12-Mar-24 8:03 PM View:	11-Mar-24 Payment of Exercise ($126.31K)	Colleran David EVP, General Counsel, Corp Sec		Anika Therapeutics Inc. - ANIK	56% 21.12K to 32.99K	0	0	--	--	Show Txns Hide Txns

12-Mar-24 8:04 PM View:	11-Mar-24 Payment of Exercise ($716.63K)	Blanchard Cheryl R President, CEO, Director Director		Anika Therapeutics Inc. - ANIK	29% 126.94K to 163.44K	0	0	--	--	Show Txns Hide Txns

12-Mar-24 8:01 PM View:	11-Mar-24 Payment of Exercise ($144.28K)	Levitz Michael L EVP, CFO, Treasurer		Anika Therapeutics Inc. - ANIK	41% 33.39K to 46.95K	0	0	--	--	Show Txns Hide Txns

12-Mar-24 8:02 PM View:	11-Mar-24 Payment of Exercise ($44.00K)	Nunes Anne SVP, Chief Operations Officer		Anika Therapeutics Inc. - ANIK	60% 6.95K to 11.09K	0	0	--	--	Show Txns Hide Txns